Press Releases
FDA approves of new Alzheimer's drug.
Learn about the new grants available this year for Macular Degeneration Research.
Johns Hopkins University’s Sheila West, Ph.D., Pharm.D., a world-renowned expert on environmental factors and disparities causing blindness, was this month awarded the 2020 Helen Keller Prize for Vision Research. The Prize, presented by BrightFocus Foundation and the Helen Keller Foundation for Research and Education, honors scientific discovery and excellence and is chosen by an independent awards committee. The award was delayed by one year because of the pandemic.
May 3, 2021—BrightFocus Foundation, a leading private funder of scientific research on diseases of mind and sight, today announced its 2021 named awards for macular degeneration and glaucoma research at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO).
BrightFocus Foundation announces $25.3 million in new grants.
BrightFocus Foundation today received the inaugural Impact Award from the Medical Technology Enterprise Consortium (MTEC) for its work supporting the scientific development of better treatments for repeated mild traumatic brain injury (mTBI). MTEC is a public-private partnership with the U.S. Department of Defense and key research, advocacy, and corporate organizations.
Press release on a new Alzheimer’s drug which shows promising results to slow disease progression.
MPTF (Motion Picture & Television Fund) and BrightFocus Foundation today announced a special Valentine’s virtual concert featuring acclaimed multi-hyphenate and Grammy-nominated vocalist Seth MacFarlane in support of the two nonprofits working together on research and care around Alzheimer’s disease.
Three scientists – renowned for scientific breakthroughs in Alzheimer’s, macular degeneration and glaucoma and who were given key early support from BrightFocus – have been elected as members of the prestigious National Academy of Medicine.
BrightFocus Foundation, a premier source of private research funding to defeat Alzheimer’s disease, macular degeneration, and glaucoma, today announced the addition of Sharyn Rossi, PhD, to its senior staff as the organization’s new Director of Scientific Programs, Neuroscience.
